We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Fevertree Drinks Plc | FEVR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 9.00 | 1.14% | 800.00 | 16:29:56 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 792.00 | 778.00 | 804.00 | 800.00 | 791.00 |
| Industry Sector |
|---|
| BEVERAGES |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 12/09/2024 | Interim | GBP | 0.0585 | 26/09/2024 | 27/09/2024 | 18/10/2024 |
| 26/03/2024 | Final | GBP | 0.109 | 16/05/2024 | 17/05/2024 | 21/06/2024 |
| 12/09/2023 | Interim | GBP | 0.0574 | 28/09/2023 | 29/09/2023 | 20/10/2023 |
| 22/03/2023 | Final | GBP | 0.1068 | 20/04/2023 | 21/04/2023 | 02/06/2023 |
| 13/09/2022 | Interim | GBP | 0.0563 | 29/09/2022 | 30/09/2022 | 21/10/2022 |
| 16/03/2022 | Final | GBP | 0.1047 | 07/04/2022 | 08/04/2022 | 27/05/2022 |
| 16/03/2022 | Special | GBP | 0.429 | 07/04/2022 | 08/04/2022 | 27/05/2022 |
| 15/09/2021 | Interim | GBP | 0.0552 | 30/09/2021 | 01/10/2021 | 22/10/2021 |
| 18/03/2021 | Final | GBP | 0.1027 | 08/04/2021 | 09/04/2021 | 28/05/2021 |
| 08/09/2020 | Interim | GBP | 0.0541 | 24/09/2020 | 25/09/2020 | 16/10/2020 |
| 22/04/2020 | Final | GBP | 0.0988 | 14/05/2020 | 15/05/2020 | 12/06/2020 |
| Top Posts |
|---|
Posted at 30/1/2025 09:48 by martywidget Sizzling Smoky flavour, shorts:Disclosed short positions in Fevertree Drinks (FEVR) Fund % short change Date changed Connor, Clark & Lunn Investment Management Ltd 0.50% 0.0% 6 Dec 2024 JPMorgan Asset Management (UK) Ltd 0.95% -0.05% 16 Dec 2024 Total 1.45% |
Posted at 30/1/2025 07:56 by aishah @sweetstocksblogFevertree's Molson Coors deal looks poor * issuing shares at lowest price in 10yrs, not the long-hoped-for big premium * FEVR itself paying upfront towards extra marketing * big profit warning for 2025, with jam from 2027 on? Was no better deal on offer? |
Posted at 30/1/2025 07:53 by bulltradept Good to see, quite a decent thing for FEVR Mgt to do. |
Posted at 04/12/2024 13:55 by wetdream Nick Train ‘in pain’ over Diageo bet and fund performancePresumably FEVR contributing to his ‘pain’. |
Posted at 02/12/2024 09:14 by castleford tiger ValueHurtsNot in the first half results they were flat. last full year sales were up 20m to 364m which........ is LESS THAN HALF MARKET CAP net profit fell £10m giving a p/e of 50+ I do understand that FEVR has never looked a sensible valuation. The big concern is the UK sales are falling. Tiger |
Posted at 13/9/2024 08:19 by masurenguy Fever-Tree commits to London listing as shares hit 8 year lowA dismal start to the British summer takes shine off sales at the mixers group Announcing first-half results, the company lowered expectations for annual revenue growth to 4-5%, from a previously guided 10% in March. Fever-Tree also cut its 2023 annual forecast at the same stage last year by 15% and took a £3.3m hit on its US division from a production issue. The update sent shares in Fever-Tree down by 100p, or 11.6%, to an eight-year low at 762½p on the Aim index. The stock remains well below the highs of almost £40 achieved before the pandemic and cost-of-living crisis shuttered pubs and wallets. In the first half, Fever-Tree reported a 2% increase in revenue to £170.6m, with the UK down 6% to £50.9 million and Europe down 12% to £44.5m. The US was up 7 per cent to £60.3m, and revenues for the rest of the world were 57% higher at £14.9m. Underlying earnings in the first half jumped by 79% to £18.2m, and the company declared a dividend up 2% at 5.85p per share. Warrillow, 49, who remains chief executive, said that the situation had improved strongly “as summer belatedly arrived. Whilst the first half was challenging, we are controlling the controllables. We’re optimistic of an acceleration of growth across the second half of the year and have seen a much more positive trading performance in July and August.” “Fevertree is doing the right things, gaining share and delivering on gross margin recovery, in a difficult market,” Investec analyst Matthew Webb said. Complete article: No position but onto my watchlist. |
Posted at 13/9/2024 06:25 by laurence llewelyn binliner An interesting watch, I am looking to replace BVIC now bought out by Carlsberg, could FEVR become the next target for a bigger player and more MnA..? 10% off yesterday and could continue south with the revised outlook..? |
Posted at 12/9/2024 07:50 by eezymunny Look at all the competition now:It used to be schweppes massive dominance which was crushed by FEVR. All down hill from here in the UK possibly.... |
Posted at 20/8/2024 09:15 by philanderer Fever-Tree can fizz again, says Deutsche BankPremium mixer business Fever-Tree (FEVR) is trading at an ‘attractive valuation’ despite the challenging backdrop, says Deutsche Bank. Analyst Deirdre Mullaney retained her ‘buy’ recommendation but reduced the target price from £16 to £14.50 on the stock, which rose 2% to 913p on Monday after a full-year preview. The shares have tumbled 9% year-to-date. Despite the downbeat sentiment towards the business, Mullaney said that she ‘continues to believe Fever-Tree is well positioned to capitalise on the long-term premium mixer opportunity given its strong brand equity and large white space opportunity overseas’. Falling costs, new supply agreements and supply chain improvements will allow ‘strong margin recovery than consensus expects in outer years’. However, Mullaney said that near-term the ‘stock will struggle given the challenging market backdrop’, leading her to revise down full-year 2024 and 2025 expectations that reflect a ‘negative weather impact over the summer and weak global spirits market’. The shares trade on 23.1 times price to earnings for 2025 which Mullaney said ‘is an attractive valuation given the long-term growth potential’. Citywire.com |
Posted at 25/7/2024 08:31 by bulltradept US recession looming, FEVR might have a few issues going forward.. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
